🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well administering ruxolitinib before, duri...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2020-12-18
Trial ID
NCT04384692
Treatments Being Tested
This phase II trial studies how well ruxolitinib phosphate works in reducin...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2014-09-02
Trial ID
NCT02131584
Treatments Being Tested
A protocol named as "HLH-DR" for patients with refractory and secondary hem...
Status
Unknown
Location
Yan Yue
Start Date
2017-03-01
Trial ID
NCT03795909
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of Ruxoli...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2020-09-01
Trial ID
NCT04582604
Treatments Being Tested
The study plan aims to include patients who have been diagnosed with steroi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-15
Trial ID
NCT06364319
Treatments Being Tested
The purpose of the study is to evaluate the effect of ruxolitinib cream on ...
Status
Terminated
Location
First Oc Dermatology
Start Date
2023-03-16
Trial ID
NCT05696392
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of Rux...
Status
Completed
Location
University of Alabama At Birmingham
Start Date
2023-06-12
Trial ID
NCT05764161
Treatments Being Tested
A randomized (1:1) phase II open label study of DSC compared to Investigato...
Status
Terminated
Location
Copenhagen Univerity Hospital
Start Date
2021-12-01
Trial ID
NCT04118556
Treatments Being Tested
This study (study ID PAC203 North America; PAC303 ex-North America) is eval...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham, (UAB) Hospital, Comprehensive Cancer Center
Start Date
2017-06-26
Trial ID
NCT03165734
Treatments Being Tested
This phase II trial studies how well ruxolitinib works in treating patients...
Status
Recruiting
Location
Stanford Cancer Institute Palo Alto
Start Date
2019-11-15
Trial ID
NCT03801434
Treatments Being Tested